Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications

Treatment of advanced melanoma with combined immune checkpoint inhibitor (ICI) therapy is complicated in up to 50% of cases by immune-related adverse events (irAE) that commonly include hepatitis, colitis and skin reactions. We previously reported that pre-therapy expansion of cytomegalovirus (CMV)-...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hannah-Lou Schilling, Gunther Glehr, Michael Kapinsky, Norbert Ahrens, Paloma Riquelme, Laura Cordero, Florian Bitterer, Hans J. Schlitt, Edward K. Geissler, Sebastian Haferkamp, James A. Hutchinson, Katharina Kronenberg
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	flow cytometry assay validation immune checkpoint inhibition immune-related adverse events prediction effector memory T cells Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/978480e0f0484366a2e24632235b94b1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications

Ejemplares similares